Barr Confirms Patent Challenge Of Razadyne(R) ER Capsules

Sat, 08 Jul 2006 11:00 AM EST

... BarrPharmaceuticals, Inc. (NYSE: BRL) today confirmed that JanssenPharmaceutica N.V., Janssen, L.P., Ortho-McNeil Neurologics, Inc. andSynaptech, Inc. ("Plaintiff") filed suit against it and its subsidiary,Barr Laboratories, Inc., relating to the patent protecting Razadyne(R) ER(Galantamine Hydrobromide Extended-Release Capsules), 8 mg, 16 mg and 24mg. [click link for full article] ...